Shimamura Y, Ishii M, Shima Y, Takenaka H, Taniguchi H, Watanabe H, Kitai S, Sugai S, Takahashi A, Kitaya T
Dept. of Surgery, National Matsudo Hospital.
Gan To Kagaku Ryoho. 1988 Aug;15(8 Pt 2):2535-9.
Transcatheter arterial embolization using lipiodol ultra-fluid (L-TAE) is frequently used for hepatocellular carcinoma (HCC). Its advantages are: (1) Excellent therapeutic and diagnostic ability in our pathological study of 153 resected tumors. (2) Preoperatively, we can localize HCC and prevent spreading of cancer cells by manipulation at hepatectomy. (3) Postoperatively, we can detect and treat recurrence early, and we hope to prevent recurrence by repeated L-TAE. (1) Liver infarction has occurred after L-TAE, because some lipiodol flows into the portal vein. Lipiodol remains long in the infarction area and interferes with the diagnosis of HCC. (2) Liver abscess has rarely occurred. (3) Repeated L-TAE does not impair the liver function much.
使用超液化碘油的经导管动脉栓塞术(L-TAE)常用于肝细胞癌(HCC)。其优点包括:(1)在我们对153例切除肿瘤的病理研究中具有出色的治疗和诊断能力。(2)术前,我们可以定位HCC并通过肝切除术时的操作防止癌细胞扩散。(3)术后,我们可以早期检测和治疗复发,并且希望通过重复L-TAE预防复发。(1)L-TAE后发生了肝梗死,因为一些碘油流入门静脉。碘油在梗死区域停留时间长并干扰HCC的诊断。(2)肝脓肿很少发生。(3)重复L-TAE对肝功能影响不大。